Favorable Toxicity Profile of Raltitrexed in Elderly Patients Treated for Colorectal Cancer: A Case Series

Publisher： Karger

E-ISSN： 1423-0003|49|5|324-327

ISSN： 0304-324x

Source： Gerontology, Vol.49, Iss.5, 2003-08, pp. : 324-327

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multicenter Phase I Study of Irinotecan plus Raltitrexed in Patients with 5-Fluorouracil-Refractory Advanced Colorectal Cancer

By  

Oncology, Vol. 63, Iss. 1, 2002-08 ,pp. : 42-47

Karger

Access to resources Recommend Favorite

Treating Non-Small-Cell Lung Cancer First Line with Erlotinib Monotherapy in Elderly Patients: Discussion of a Case Series

By  

Oncology Research and Treatment, Vol. 30, Iss. 10, 2007-09 ,pp. : 515-518

Karger

Access to resources Recommend Favorite

A Phase I Study of Raltitrexed (Tomudex) Combined with Carmofur in Metastatic Colorectal Cancer

By  

Oncology, Vol. 61, Iss. 2, 2001-08 ,pp. : 113-119

Karger

Access to resources Recommend Favorite

First-Line Treatment with Irinotecan and Raltitrexed in Metastatic Colorectal Cancer

By  

Oncology, Vol. 68, Iss. 1, 2005-04 ,pp. : 58-63

Karger

Access to resources Recommend Favorite

Serum Lipid Profile in Colorectal Cancer Patients with and without Synchronous Distant Metastases

By  

Oncology, Vol. 68, Iss. 4-6, 2005-08 ,pp. : 371-374

Karger

Access to resources Recommend Favorite